← Back to Clinical Trials
Recruiting NCT04960098

NCT04960098 Patient-reported Outcome Measures in Patient Underwent Total Hip and Knee Arthroplasty

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04960098
Status Recruiting
Phase
Sponsor I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Condition Hip Osteoarthritis
Study Type OBSERVATIONAL
Enrollment 5,816 participants
Start Date 2016-01-12
Primary Completion 2050-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
arthroplasty

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 5,816 participants in total. It began in 2016-01-12 with a primary completion date of 2050-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Registry of Galeazzi Orthopedic Institute: provides for the regular and systematic collection of all data (clinical and some PROMs) obtained from patients undergoing hip and knee arthroplasty to which questionnaires are proposed investigating the specific functional sphere of the joints undergoing surgery (Knee injuryOsteoarthritisOutcomeScore (KOOS-PS) and Hip injuryOsteoarthritisOutcomeScore (HOOS-PS) but also the sphere of general health (ShortForm health survey-12 (SF-12) and VisualAnalogueScale (VAS)) , in addition, of course, to the satisfaction rate.

Eligibility Criteria

Inclusion Criteria: * male and female * age more than 18 * patient underwent hip or knee arthroplasty Exclusion Criteria: * age less than 18 * comorbidity that can results in the difficulty to come back for the follow up

Contact & Investigator

Central Contact

Michele Ulivi

✉ micheleulivi@masn.com

📞 00390266214946

Frequently Asked Questions

Who can join the NCT04960098 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hip Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04960098 currently recruiting?

Yes, NCT04960098 is actively recruiting participants. Contact the research team at micheleulivi@masn.com for enrollment information.

Where is the NCT04960098 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT04960098 clinical trial?

NCT04960098 is sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. The trial plans to enroll 5,816 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology